US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

CEL-SCI Corp

0.2900

-0.0065-2.19%

Volume:699.31K

Turnover:203.88K

Market Cap:24.40M

PE:-0.60

High:0.3069

Open:0.3000

Low:0.2863

Close:0.2965

Loading ...

Overview Company News Filings

CEL-SCI Announces Proposed Public Offering of Common Stock

THOMSON REUTERS

CEL-SCI Announces Proposed Public Offering of Common Stock

Amex Halt Add Info Lst 0.840000

THOMSON REUTERS

Innocan Pharma Provides its Annual "State of Research and Development" Update for 2024

CEL-SCI Highlights Biological Rationale for the Use of Multikine in the Confirmatory Registration Head and Neck Cancer Study

CVM: CRO Selected for Registrational Trial

Zacks Small Cap Research

BRIEF-Cel-Sci Corp Says On November 13, Patricia B Prichep Has Assumed The Duties Of Chief Financial And Operations Officer

CEL-SCI Corp: on November 13, Patricia B Prichep Has Assumed the Duties of Chief Financial and Operations Officer

THOMSON REUTERS

Innocan to Direct Full Focus on Following Positive FDA Engagement and Significant Potential Market Demand

CEL-SCI, FDA agree on Phase 3 trial design for cancer drug

U.S. FDA and CEL-SCI Agree on Use of Pd-L1 Biomarker to Select Head and Neck Cancer Patients for Marketing Registration Study to Commence Q1 2025

THOMSON REUTERS

U.S. FDA and CEL-SCI Agree on Use of PD-L1 Biomarker to Select Head and Neck Cancer Patients for Marketing Registration Study to Commence Q1 2025

Press Release: GERDAU S.A. - CONSOLIDATED INFORMATION

Press Release: ITAÚ UNIBANCO - Projections

Solana News: Canary Capital Files for New ETF, What’s Next for SOL Price?

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/CVM/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CVM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CVM\",,,,,undefined,":{"symbol":"CVM","market":"US","secType":"STK","nameCN":"CEL-SCI Corp","latestPrice":0.29,"timestamp":1745608690378,"preClose":0.2965,"halted":0,"volume":699306,"delay":0,"floatShares":82268700,"shares":84124041,"eps":-0.479643,"marketStatus":"Trading","change":-0.0065,"latestTime":"04-25 15:18:30 EDT","open":0.3,"high":0.3069,"low":0.2863,"amount":203879.5873536,"amplitude":0.069477,"askPrice":0.2927,"askSize":200,"bidPrice":0.2861,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-0.479643,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1745611200000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":433828800000,"exchange":"AMEX","adjPreClose":0.2965,"preHourTrading":{"tag":"盘前","latestPrice":0.2997,"preClose":0.2965,"latestTime":"09:24 EDT","volume":9971,"amount":2988.12463534,"timestamp":1745587468756},"postHourTrading":{"tag":"盘后","latestPrice":0.2973,"preClose":0.2965,"latestTime":"19:43 EDT","volume":21936,"amount":6540.084,"timestamp":1745538216997},"volumeRatio":0.630072,"impliedVol":1.8864,"impliedVolPercentile":0.756},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CVM\",,,,,undefined,":{"symbol":"CVM","floatShares":82268700,"roa":"-61.48%","roe":"-233.26%","lyrEps":-0.510314,"volumeRatio":0.630072,"shares":84124041,"dividePrice":0,"high":0.3069,"amplitude":0.069477,"preClose":0.2965,"low":0.2863,"week52Low":0.18,"pbRate":"2.16","week52High":2.39,"institutionHeld":0.1743,"latestPrice":0.29,"eps":-0.479643,"divideRate":0,"volume":699306,"delay":0,"ttmEps":-0.479643,"open":0.3,"prevYearClose":0.3999,"prevWeekClose":0.2548,"prevMonthClose":0.2304,"prevQuarterClose":0.2304,"fiveDayClose":0.2548,"twentyDayClose":0.2389,"sixtyDayClose":0.3854},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CVM\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2494355237","title":"CEL-SCI Announces Proposed Public Offering of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2494355237","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2494355237?lang=en_us&edition=fundamental","pubTime":"2024-12-28 06:05","pubTimestamp":1735337101,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241227:nTUAY3TBX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CVM","BK4139"],"gpt_icon":0},{"id":"2494356918","title":"CEL-SCI Announces Proposed Public Offering of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2494356918","media":"Business Wire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2494356918?lang=en_us&edition=fundamental","pubTime":"2024-12-28 06:05","pubTimestamp":1735337100,"startTime":"0","endTime":"0","summary":"VIENNA, Va., December 27, 2024----CEL-SCI Corporation  , a clinical stage cancer immunotherapy company, today announced that it intends to offer to sell shares of its common stock  in a best efforts public offering. The offering is subject to market conditions and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.The Company intends to use the net proceeds from this offering to fund the continued development of Multikine*, for general corporate purposes, and working capital.ThinkEquity is acting as sole placement agent for the offering.Multikine , a true first-line cancer therapy, has been dosed in over 740 patients and received Orphan Drug designation from the FDA for neoadjuvant therapy in patients with squamous cell carcinoma  of the head and neck. Based on the data from the completed randomized controlled Phase 3 study, the FDA concurred with CEL-SCI’s target patient selection criteria and gave the go-ah","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cel-sci-announces-proposed-public-220500451.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","CEL","CVM"],"gpt_icon":0},{"id":"2492410922","title":"Amex Halt  Add Info Lst 0.840000","url":"https://stock-news.laohu8.com/highlight/detail?id=2492410922","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492410922?lang=en_us&edition=fundamental","pubTime":"2024-12-20 01:12","pubTimestamp":1734628379,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241219:nAQN2JUUSX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CVM","BK4139"],"gpt_icon":0},{"id":"2491936844","title":"Innocan Pharma Provides its Annual \"State of Research and Development\" Update for 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2491936844","media":"CNW Group","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491936844?lang=en_us&edition=fundamental","pubTime":"2024-12-13 05:01","pubTimestamp":1734037260,"startTime":"0","endTime":"0","summary":"HERZLIYA, Israel and CALGARY, Alberta, Dec. 12, 2024 /CNW/ -- Innocan Pharma Corporation     a pharmaceutical technology company focusing on developing innovative drug delivery platform technologies and an owner of a proprietary intellectual property portfolio, is pleased to share its annual \"State of Research and Development\" update for 2024. This year, the Company achieved significant milestones in advancing research and development for its drug delivery platforms as well as its intellectual property portfolio.During 2024, Innocan achieved significant milestones in both scientific and regulatory domains. Preclinical studies of its liposome-cannabidiol technology (LPT-CBD( demonstrated high CBD bioavailability, along with long-lasting pain relief and improved well-being in various animal models. Building on this compelling data, the Company secured agreement from the United States Food and Drug Administration (FDA) on the preclinical and Phase 1 clinical development plan to advance LP","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/0E.7l4y9jnds4XLTwEXGMQ--~B/aD0yODM7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/cnwgroup.com/7706f970d25ba77672f989a1db7cd166","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/0E.7l4y9jnds4XLTwEXGMQ--~B/aD0yODM7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/cnwgroup.com/7706f970d25ba77672f989a1db7cd166"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/innocan-pharma-provides-annual-state-210100474.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4557","INN","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","BK4139","LU1883839398.USD","IE0034235188.USD","INNPF","ACB","BK4588","BK4007","BK4218","STT","BK4135","LU0061475181.USD","BK4181","IE00B64PRP62.GBP","CVM","BK4585"],"gpt_icon":0},{"id":"2490879633","title":"CEL-SCI Highlights Biological Rationale for the Use of Multikine in the Confirmatory Registration Head and Neck Cancer Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2490879633","media":"Business Wire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490879633?lang=en_us&edition=fundamental","pubTime":"2024-12-12 22:15","pubTimestamp":1734012900,"startTime":"0","endTime":"0","summary":"Multikine is the first cancer immunotherapy to show pre-surgical tumor regression in head and neck cancer in just 3 weeks - confirmed by pathology at surgery. Factors supporting the go-ahead for the 212-person registration study in the target population include:. Multikine led to significant rates of tumor regression. Pre-surgical tumor regressions were confirmed at surgery and forecast survival benefit. Target population is likely to show significant survival prolongation in the confirmatory study. Confirmatory study target population selection is based on:. Strong statistical significance in a large subgroup of 114 patients. Strong biological rationale for the results based on Multikine’s mechanism of action . The Phase 3 study missed the primary endpoint of 10% improvement in overall survival  in the ITT population  but showed a 46.5-month  OS benefit vs control  in the patients who received Multikine followed by surgery and radiotherapy. In the other group","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/8BmWiXx5HRLEXXBZF8uK2Q--~B/aD0yNDA7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/51c62ce853d0e3d5dff54cee0a1524f8","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/8BmWiXx5HRLEXXBZF8uK2Q--~B/aD0yNDA7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/51c62ce853d0e3d5dff54cee0a1524f8"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cel-sci-highlights-biological-rationale-141500652.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4161","BK4097","ITT","LU0053671581.USD","OS","BK4585","CVM","SAP","CEL","BK4023","BK4528","BK4588","BK4139","LU0054578231.USD"],"gpt_icon":0},{"id":"2490502776","title":"CVM: CRO Selected for Registrational Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2490502776","media":"Zacks Small Cap Research","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490502776?lang=en_us&edition=fundamental","pubTime":"2024-12-09 17:39","pubTimestamp":1733737140,"startTime":"0","endTime":"0","summary":"CEL-SCI Corporation  has made progress advancing the prerequisites for the upcoming registrational trial, selecting the contract research organization  that will run it and coming to an agreement with the FDA on which biomarkers are appropriate for selecting patients. The view of oncologists as expressed by the FDA’s ODAC is that using checkpoint inhibitors to treat low PD-L1 expressing patients provides limited efficacy and could even be harmful. This view opens the door for the use of Multikine, if approved, in the low expressing PD-L1 patient population based on its efficacy in this group.FDA ODAC opines against use of checkpoints in low PD-L1 expression patients – October 2024. FDA agrees to use of PD-L1 biomarker in Multikine registration study – November 2024. The 79 patients who were recommended to receive only radiotherapy benefited to an even greater degree from pre-surgery treatment with Multikine compared to the wider 114 patient group. This target low risk population  had a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cvm-cro-selected-registrational-trial-093900095.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4097","BK4192","CVM","BK4139","OS","PET"],"gpt_icon":0},{"id":"2483753404","title":"BRIEF-Cel-Sci Corp Says On November 13, Patricia B Prichep Has Assumed The Duties Of Chief Financial And Operations Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2483753404","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483753404?lang=en_us&edition=fundamental","pubTime":"2024-11-16 07:04","pubTimestamp":1731711848,"startTime":"0","endTime":"0","summary":"BRIEF-Cel-Sci Corp Says On November 13, Patricia B Prichep Has Assumed The Duties Of Chief Financial And Operations OfficerNov 15  - CEL-SCI Corp CVM.A:CEL-SCI CORP: ON NOVEMBER 13, PATRICIA B PRICHEP HAS ASSUMED THE DUTIES OF CHIEF FINANCIAL AND OPERATIONS OFFICERSource text: [ID:n0001654954-24-014554]Further company coverage: CVM.A ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241115:nFWN3MM18X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CVM"],"gpt_icon":0},{"id":"2483533711","title":"CEL-SCI Corp: on November 13, Patricia B Prichep Has Assumed the Duties of Chief Financial and Operations Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2483533711","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483533711?lang=en_us&edition=fundamental","pubTime":"2024-11-16 05:33","pubTimestamp":1731706438,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241115:nFWN3MM18X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CVM","BK4139"],"gpt_icon":0},{"id":"2482630997","title":"Innocan to Direct Full Focus on Following Positive FDA Engagement and Significant Potential Market Demand","url":"https://stock-news.laohu8.com/highlight/detail?id=2482630997","media":"CNW Group","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482630997?lang=en_us&edition=fundamental","pubTime":"2024-11-12 05:01","pubTimestamp":1731358860,"startTime":"0","endTime":"0","summary":"A recent National Pet Owners Survey demonstrates a significant addressable market for Innocan's veterinary product. Innocan has received FDA support to advance its LPT-CBD platform for human use under the 505 abbreviated pathway, offering a quicker route to commercial approval. The FDA has also aligned on Innocan's non-clinical development plan and Phase I clinical study design for the LPT-CBD's Investigational New Drug  filing, moving the Company closer to an accelerated approval process. Furthermore, it is noted that Innocan has made strong progress with the FDA's Center for Veterinary Medicine  with the issuance of an Investigational New Animal Drug  designation in July.Following the positive response of the FDA regarding the LPT-CBT product reported in September 2024, as well as the continued progress of the LPT-CBD project and significant addressable market potential for LPT-CBD, Innocan has decided to shift its focus and resources in its pharmaceutical division to the LPT-CBD pro","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/KJLSIxEyVP4G61TXboPO4Q--~B/aD0xNzg7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/cnwgroup.com/8b2fd4dbe4ed1dd3719ec221a12ddb50","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/KJLSIxEyVP4G61TXboPO4Q--~B/aD0xNzg7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/cnwgroup.com/8b2fd4dbe4ed1dd3719ec221a12ddb50"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/innocan-direct-full-focus-following-210100841.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["INN","BK4567","ACB","BK4504","BK4557","BK4018","BK4585","BK4139","BK4218","BK4007","BK4532","CVM","BK4588","BK4533","INNPF","BK4181","CLX","LU1571399168.USD"],"gpt_icon":0},{"id":"2481135830","title":"CEL-SCI, FDA agree on Phase 3 trial design for cancer drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2481135830","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481135830?lang=en_us&edition=fundamental","pubTime":"2024-11-08 00:31","pubTimestamp":1730997090,"startTime":"0","endTime":"0","summary":"hapabapa CEL-SCI Corporation (NYSE:CVM) announced Thursday that the FDA agreed to its proposal to use the PD-L1 biomarker status in selecting patients for a registrational trial for its lead cancer therapy, Multikine. Accordingly, the 212-subject confirmatory trial is expected to enroll newly","market":"hk","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1413289936/image_1413289936.jpg?io=getty-c-w750","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1413289936/image_1413289936.jpg?io=getty-c-w750"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4261655-cel-sci-fda-agree-multikine-trial-design","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha_trending_news","symbols":["BK4139","CVM","CEL"],"gpt_icon":0},{"id":"2481904795","title":"U.S. FDA and CEL-SCI Agree on Use of Pd-L1 Biomarker to Select Head and Neck Cancer Patients for Marketing Registration Study to Commence Q1 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2481904795","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481904795?lang=en_us&edition=fundamental","pubTime":"2024-11-07 21:17","pubTimestamp":1730985448,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241107:nFWN3ME0ZL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CVM"],"gpt_icon":0},{"id":"2481226902","title":"U.S. FDA and CEL-SCI Agree on Use of PD-L1 Biomarker to Select Head and Neck Cancer Patients for Marketing Registration Study to Commence Q1 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2481226902","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481226902?lang=en_us&edition=fundamental","pubTime":"2024-11-07 21:15","pubTimestamp":1730985300,"startTime":"0","endTime":"0","summary":"Biomarker used to select patients who are more likely have favorable outcomes, supporting a successful confirmatory Registration Study. \"To our knowledge, Multikine is the only neoadjuvant immunotherapy that has shown overall survival benefit in the low and negative PD-L1 head and neck cancer population. This underscores the critical importance of having reached an agreement with the FDA on the method for identifying and selecting patients with low PD-L1 tumor expression for our upcoming confirmatory Registration study,\" stated CEL-SCI CEO Geert Kersten.CEL-SCI believes that boosting a patient’s immune system while it is still intact should provide the greatest possible impact on survival. Multiki","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/pMk2IkM1C.llWeYfb0ZgFA--~B/aD0yNDA7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/a281976e7754b0b2f5a56aebabbe7471","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/pMk2IkM1C.llWeYfb0ZgFA--~B/aD0yNDA7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/a281976e7754b0b2f5a56aebabbe7471"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/u-fda-cel-sci-agree-131500730.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CEL","ADC","BK4080","LU1169589451.USD","BK4231","CVM","BK4023","SLCT","LU1169590202.USD","BK4139","PD"],"gpt_icon":0},{"id":"2481668503","title":"Press Release: GERDAU S.A. - CONSOLIDATED INFORMATION","url":"https://stock-news.laohu8.com/highlight/detail?id=2481668503","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481668503?lang=en_us&edition=fundamental","pubTime":"2024-11-06 06:35","pubTimestamp":1730846100,"startTime":"0","endTime":"0","summary":"SO PAULO, Nov. 5, 2024 /PRNewswire/ -- 3Q24 Highlights. Adjusted EBITDA  of R$ 3.0 billion in the third quarter, 14.9% higher compared to 2Q24.Investments  totaled R$ 1.5 billion in 3Q24, of which R$ 589 million was allocated to Maintenance and R$ 920 million was directed to the Competitiveness of the Business Divisions.Dividend distribution in the amount of R$ 0.30 per share, equivalent to R$ 619,4 million, to be paid based on 3Q24 results.Share buyback program of Gerdau S.A., by the end of October 2024, 39.6 million shares were repurchased, equivalent to R$ 729.4 million.The 3Q24 Valuation Guide is also available at Gerdau's website.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["III","BK4134","IE00B1B80R65.USD","BK4006","LU0532187761.SGD","CVM","CNSL","LU0210535034.USD","GGB","BK4139","BK4115"],"gpt_icon":0},{"id":"2481566213","title":"Press Release: ITAÚ UNIBANCO - Projections","url":"https://stock-news.laohu8.com/highlight/detail?id=2481566213","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481566213?lang=en_us&edition=fundamental","pubTime":"2024-11-05 06:39","pubTimestamp":1730759940,"startTime":"0","endTime":"0","summary":"SO PAULO, Nov. 4, 2024 /PRNewswire/ -- Itaú Unibanco Holding S.A. , in compliance with the provisions in Article 157, paragraph 4 of Law No. 6,404/76 and in Resolution No. 44/21 of the Brazilian Securities and Exchange Commission , informs its stockholders and the market in general that it released as of this date its revised projections for the year 2024 in accordance with item 3  of the Reference Form.with clients          4.5% and 7.5%        5.5% and 8.5%. fees and results      5.0% and 8.0%        5.5% and 8.5%. Composed of results from loan losses, impairment and discounts granted; . Commissions and fees (+) income from insurance, pension plan and premium bonds. operations (-) expenses for claims (-) insurance, pension plan and premium. bonds selling expenses;  Considers pro forma adjustments in 2023 of the. sale of Banco Itaú Argentina;  Core expenses below inflation.It is important to mention that since July/24 the company has been considering a cost of capital of around 14.0% ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0029865408.USD","CVM","IE00B1B80R65.USD","BK4139","LU0050427557.USD","LU0320763518.SGD","LU0229945570.USD","IE00B0JY6N72.USD","LU0543330566.HKD","LU0265266980.USD","LU0256859116.SGD","BK4585","LU0072463663.USD","LU0128526570.USD","LU0228659784.USD","ITUB","LU0456842615.SGD","LU0572108347.SGD","LU0106259046.USD","ITA","BK4207","LU0788109048.HKD","LU0532187761.SGD","BK4588"],"gpt_icon":0},{"id":"2479745580","title":"Solana News: Canary Capital Files for New ETF, What’s Next for SOL Price?","url":"https://stock-news.laohu8.com/highlight/detail?id=2479745580","media":"CoinMarketCap","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479745580?lang=en_us&edition=fundamental","pubTime":"2024-10-31 11:14","pubTimestamp":1730344483,"startTime":"0","endTime":"0","summary":"Amid the growing Solana  dominance in the web3 space, Canary Capital, an investment management firm founded by Steven McClurg who is one of the founding team of Valkyrie Funds, has filed with the United States Securities and Exchange Commission  to offer its spot ETF. Filed on Wednesday, October 30, the Canary Solana ETF aims to provide institutional investors with a secure and highly liquid gateway to investing in one of the fast-growing altcoins.Canary Capital has aggressively doubled down on its focus in the altcoin market despite the low traction registered with the Spot Ether ETFs. Already, the firm has filed for a spot Litecoin  ETF and spot XRP ETF, which may be approved next year. The firm’s first altcoin offering was the Canary HBAR Trust, which ensures institutional investors have access to the growing Hedera network.From a technical analysis standpoint, SOL price must consistently close above the macro falling logarithmic trend and also July’s peak to invalidate potential sh","market":"us","thumbnail":"https://academy-public.coinmarketcap.com/srd-optimized-uploads/dc9cd3289fb94751860465538b7aa1a4.webp","type":0,"news_type":0,"thumbnails":["https://academy-public.coinmarketcap.com/srd-optimized-uploads/dc9cd3289fb94751860465538b7aa1a4.webp"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://coinmarketcap.com/community/articles/6722f623a1d0a9668b6168a4/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"coinmarketcap_highlight","symbols":["BK4585","LTC","BK4203","BK4519","FDN","LTC.USD.HKCC","BK4225","BK4139","BK4550","CVM","SOL","BK4129","AVAX.USD.HKCC","BK4588"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":55,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CVM\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-14","symbol":"CVM","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1739509200000,"reportTimeType":"post","actualEps":-0.11},{"market":"US","date":"2025-01-13","symbol":"CVM","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1736744400000,"reportTimeType":"post","actualEps":-0.09},{"date":"2024-08-15","symbol":"CVM","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2024/06","expectedEps":-0.13,"defaultRemindTime":1723708800000,"name":null,"time":"Pre-Market","dateTimestamp":1723694400000,"actualEps":-0.14},{"date":"2024-05-15","symbol":"CVM","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1715803200000,"name":null,"time":"Post Market","dateTimestamp":1715745600000,"actualEps":null},{"date":"2024-02-15","symbol":"CVM","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2023/12","expectedEps":null,"defaultRemindTime":1707987600000,"name":null,"time":"Pre-Market","dateTimestamp":1707973200000,"actualEps":-0.14}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CVM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CVM\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1741665600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CVM\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CVM","date":"2025-04-24","current":-0.864618,"percent":0.975649,"low":-36.303853,"twenty":-16.210733,"median":-4.067958,"eighty":-2.303265,"high":-0.528588,"avg":-8.205977,"sd":7.725673,"marketCap":24160424},"quantilePoints":[{"date":"2020-05-01","current":-21.240434,"twenty":-7.318328,"median":-2.479965,"eighty":-0.817762,"marketCap":614101360},{"date":"2020-05-08","current":-17.413353,"twenty":-7.318328,"median":-2.479965,"eighty":-0.817762,"marketCap":549078513},{"date":"2020-05-15","current":-18.738152,"twenty":-7.489378,"median":-2.479965,"eighty":-0.817762,"marketCap":590852135},{"date":"2020-05-22","current":-16.697245,"twenty":-7.601141,"median":-2.479965,"eighty":-0.817762,"marketCap":526498177},{"date":"2020-05-29","current":-15.909526,"twenty":-7.659518,"median":-2.479965,"eighty":-0.817762,"marketCap":501659807},{"date":"2020-06-05","current":-16.947883,"twenty":-7.762127,"median":-2.479965,"eighty":-0.817762,"marketCap":534401294},{"date":"2020-06-12","current":-15.420186,"twenty":-7.879311,"median":-2.479965,"eighty":-0.817762,"marketCap":486229910},{"date":"2020-06-19","current":-16.279515,"twenty":-7.985806,"median":-2.479965,"eighty":-0.817762,"marketCap":513326314},{"date":"2020-06-26","current":-18.189136,"twenty":-8.062403,"median":-2.479965,"eighty":-0.817762,"marketCap":573540544},{"date":"2020-07-02","current":-16.529405,"twenty":-8.151538,"median":-2.479965,"eighty":-0.817762,"marketCap":521205853},{"date":"2020-07-10","current":-17.470103,"twenty":-8.186901,"median":-2.479965,"eighty":-0.817762,"marketCap":550867974},{"date":"2020-07-17","current":-17.665573,"twenty":-8.266839,"median":-2.479965,"eighty":-0.817762,"marketCap":557031532},{"date":"2020-07-24","current":-16.236201,"twenty":-8.314192,"median":-2.479965,"eighty":-0.817762,"marketCap":511960516},{"date":"2020-07-31","current":-15.283286,"twenty":-8.342981,"median":-2.479965,"eighty":-0.817762,"marketCap":481913172},{"date":"2020-08-07","current":-14.892347,"twenty":-8.412596,"median":-2.479965,"eighty":-0.817762,"marketCap":469586056},{"date":"2020-08-14","current":-16.503475,"twenty":-8.470363,"median":-2.479965,"eighty":-0.817762,"marketCap":490912107},{"date":"2020-08-21","current":-16.555414,"twenty":-8.562705,"median":-2.479965,"eighty":-0.817762,"marketCap":492457071},{"date":"2020-08-28","current":-17.503292,"twenty":-8.806363,"median":-2.479965,"eighty":-0.817762,"marketCap":520652652},{"date":"2020-09-04","current":-17.607169,"twenty":-8.984749,"median":-2.479965,"eighty":-0.817762,"marketCap":523742579},{"date":"2020-09-11","current":-17.204646,"twenty":-9.06225,"median":-2.479965,"eighty":-0.817762,"marketCap":511769113},{"date":"2020-09-18","current":-18.619971,"twenty":-9.115153,"median":-2.479965,"eighty":-0.817762,"marketCap":553869364},{"date":"2020-09-25","current":-16.51646,"twenty":-9.194573,"median":-2.479965,"eighty":-0.817762,"marketCap":491298348},{"date":"2020-10-02","current":-17.620154,"twenty":-9.28401,"median":-2.479965,"eighty":-0.817762,"marketCap":524128819},{"date":"2020-10-09","current":-19.308157,"twenty":-9.372965,"median":-2.479965,"eighty":-0.817762,"marketCap":574340129},{"date":"2020-10-16","current":-20.80139,"twenty":-9.416922,"median":-2.479965,"eighty":-0.817762,"marketCap":618757825},{"date":"2020-10-23","current":-17.022861,"twenty":-9.659475,"median":-2.479965,"eighty":-0.817762,"marketCap":506361741},{"date":"2020-10-30","current":-15.665686,"twenty":-9.745942,"median":-2.479965,"eighty":-0.817762,"marketCap":465991240},{"date":"2020-11-06","current":-15.066665,"twenty":-9.920207,"median":-2.479965,"eighty":-0.817762,"marketCap":448172789},{"date":"2020-11-13","current":-16.499106,"twenty":-10.207212,"median":-2.479965,"eighty":-0.817762,"marketCap":490782129},{"date":"2020-11-20","current":-15.900085,"twenty":-10.500982,"median":-2.479965,"eighty":-0.817762,"marketCap":472963678},{"date":"2020-11-27","current":-16.850704,"twenty":-10.692293,"median":-2.479965,"eighty":-0.817762,"marketCap":501240786},{"date":"2020-12-04","current":-15.652664,"twenty":-11.010512,"median":-2.479965,"eighty":-0.817762,"marketCap":465603883},{"date":"2020-12-11","current":-19.339597,"twenty":-11.212214,"median":-2.482557,"eighty":-0.817762,"marketCap":575275353},{"date":"2020-12-18","current":-17.48182,"twenty":-12.418034,"median":-2.492735,"eighty":-0.817762,"marketCap":520013934},{"date":"2020-12-24","current":-17.120957,"twenty":-12.792988,"median":-2.500417,"eighty":-0.817762,"marketCap":509279701},{"date":"2020-12-31","current":-15.310637,"twenty":-13.515253,"median":-2.518522,"eighty":-0.817762,"marketCap":463559822},{"date":"2021-01-08","current":-18.25196,"twenty":-13.798902,"median":-2.526554,"eighty":-0.817762,"marketCap":552614196},{"date":"2021-01-15","current":-18.742981,"twenty":-14.056407,"median":-2.535735,"eighty":-0.817762,"marketCap":567480812},{"date":"2021-01-22","current":-18.716712,"twenty":-14.394355,"median":-2.535735,"eighty":-0.817762,"marketCap":566685464},{"date":"2021-01-29","current":-32.770663,"twenty":-14.574252,"median":-2.535735,"eighty":-0.817762,"marketCap":992196654},{"date":"2021-02-05","current":-30.984367,"twenty":-14.773602,"median":-2.535735,"eighty":-0.817762,"marketCap":938112989},{"date":"2021-02-12","current":-29.127713,"twenty":-14.836217,"median":-2.557047,"eighty":-0.817762,"marketCap":954464496},{"date":"2021-02-19","current":-24.539016,"twenty":-14.892347,"median":-2.570115,"eighty":-0.817762,"marketCap":804100875},{"date":"2021-02-26","current":-21.954009,"twenty":-14.992143,"median":-2.570115,"eighty":-0.817762,"marketCap":719394684},{"date":"2021-03-05","current":-24.019541,"twenty":-15.091995,"median":-2.57578,"eighty":-0.817762,"marketCap":787078578},{"date":"2021-03-12","current":-25.293492,"twenty":-15.193271,"median":-2.602518,"eighty":-0.817762,"marketCap":828823735},{"date":"2021-03-19","current":-21.892166,"twenty":-15.25121,"median":-2.616574,"eighty":-0.817762,"marketCap":717368220},{"date":"2021-03-26","current":-20.333741,"twenty":-15.328113,"median":-2.629256,"eighty":-0.818503,"marketCap":666301330},{"date":"2021-04-01","current":-20.370846,"twenty":-15.523478,"median":-2.642183,"eighty":-0.818503,"marketCap":667517208},{"date":"2021-04-09","current":-19.950319,"twenty":-15.637604,"median":-2.682036,"eighty":-0.817762,"marketCap":653737254},{"date":"2021-04-16","current":-21.607692,"twenty":-15.727789,"median":-2.952382,"eighty":-0.817762,"marketCap":708046486},{"date":"2021-04-23","current":-30.203768,"twenty":-15.842734,"median":-3.11969,"eighty":-0.817762,"marketCap":989724968},{"date":"2021-04-30","current":-29.845083,"twenty":-15.945112,"median":-3.220938,"eighty":-0.817762,"marketCap":977971478},{"date":"2021-05-07","current":-26.456126,"twenty":-16.001259,"median":-3.342026,"eighty":-0.817762,"marketCap":866921256},{"date":"2021-05-14","current":-27.618761,"twenty":-16.12622,"median":-3.420304,"eighty":-0.817762,"marketCap":905018777},{"date":"2021-05-21","current":-24.359361,"twenty":-16.194926,"median":-3.471932,"eighty":-0.817762,"marketCap":850039002},{"date":"2021-05-28","current":-25.215104,"twenty":-16.242394,"median":-3.499441,"eighty":-0.817762,"marketCap":879900815},{"date":"2021-06-04","current":-28.978027,"twenty":-16.27136,"median":-3.562279,"eighty":-0.817762,"marketCap":1011210978},{"date":"2021-06-11","current":-27.068328,"twenty":-16.313109,"median":-3.626813,"eighty":-0.817762,"marketCap":944570533},{"date":"2021-06-18","current":-27.019578,"twenty":-16.463579,"median":-3.656855,"eighty":-0.817762,"marketCap":942869371},{"date":"2021-06-25","current":-30.566127,"twenty":-16.539276,"median":-3.704254,"eighty":-0.817762,"marketCap":1066628950},{"date":"2021-07-02","current":-9.859342,"twenty":-16.554579,"median":-3.81599,"eighty":-0.817762,"marketCap":344049473},{"date":"2021-07-09","current":-10.888143,"twenty":-16.554579,"median":-3.886922,"eighty":-0.817762,"marketCap":379950287},{"date":"2021-07-16","current":-9.712371,"twenty":-16.554579,"median":-3.975297,"eighty":-0.817762,"marketCap":338920785},{"date":"2021-07-23","current":-9.40618,"twenty":-16.554579,"median":-4.078552,"eighty":-0.817762,"marketCap":328236019},{"date":"2021-07-30","current":-9.834847,"twenty":-16.554579,"median":-4.143086,"eighty":-0.817762,"marketCap":343194691},{"date":"2021-08-06","current":-11.231077,"twenty":-16.554579,"median":-4.233433,"eighty":-0.817762,"marketCap":391917226},{"date":"2021-08-13","current":-11.466148,"twenty":-16.554579,"median":-4.310874,"eighty":-0.817762,"marketCap":388544194},{"date":"2021-08-20","current":-12.10104,"twenty":-16.554579,"median":-4.432946,"eighty":-0.817762,"marketCap":410058269},{"date":"2021-08-27","current":-13.700968,"twenty":-16.554579,"median":-4.607581,"eighty":-0.817762,"marketCap":464273738},{"date":"2021-09-03","current":-14.615212,"twenty":-16.554579,"median":-4.744934,"eighty":-0.817762,"marketCap":495254006},{"date":"2021-09-10","current":-14.577119,"twenty":-16.554579,"median":-4.782394,"eighty":-0.817762,"marketCap":493963162},{"date":"2021-09-17","current":-15.440572,"twenty":-16.554579,"median":-4.949865,"eighty":-0.817762,"marketCap":523222304},{"date":"2021-09-24","current":-15.173917,"twenty":-16.554579,"median":-5.094561,"eighty":-0.817762,"marketCap":514186392},{"date":"2021-10-01","current":-14.462838,"twenty":-16.554579,"median":-5.319321,"eighty":-0.817762,"marketCap":490090628},{"date":"2021-10-08","current":-12.862911,"twenty":-16.554579,"median":-5.785203,"eighty":-0.817762,"marketCap":435875159},{"date":"2021-10-15","current":-13.205752,"twenty":-16.554579,"median":-6.107319,"eighty":-0.817762,"marketCap":447492760},{"date":"2021-10-22","current":-14.500932,"twenty":-16.554579,"median":-6.705482,"eighty":-0.817762,"marketCap":491381473},{"date":"2021-10-29","current":-14.221579,"twenty":-16.554579,"median":-7.035014,"eighty":-0.817762,"marketCap":481915280},{"date":"2021-11-05","current":-15.2755,"twenty":-16.554579,"median":-7.331381,"eighty":-0.817762,"marketCap":517628644},{"date":"2021-11-12","current":-15.478665,"twenty":-16.554579,"median":-7.497948,"eighty":-0.817762,"marketCap":524513148},{"date":"2021-11-19","current":-13.942227,"twenty":-16.554579,"median":-7.614194,"eighty":-0.817762,"marketCap":472449087},{"date":"2021-11-26","current":-12.977191,"twenty":-16.554579,"median":-7.668581,"eighty":-0.817762,"marketCap":439747693},{"date":"2021-12-03","current":-10.843954,"twenty":-16.554579,"median":-7.788232,"eighty":-0.827975,"marketCap":367460401},{"date":"2021-12-10","current":-11.237587,"twenty":-16.554579,"median":-7.8854,"eighty":-0.859111,"marketCap":380799127},{"date":"2021-12-17","current":-10.323343,"twenty":-16.554579,"median":-7.988477,"eighty":-0.879153,"marketCap":349818859},{"date":"2021-12-23","current":-9.859358,"twenty":-16.554579,"median":-8.049389,"eighty":-0.891677,"marketCap":361956448},{"date":"2021-12-31","current":-8.363374,"twenty":-16.554579,"median":-8.158065,"eighty":-0.93448,"marketCap":307035935},{"date":"2022-01-07","current":-7.291449,"twenty":-16.554301,"median":-8.158065,"eighty":-0.951103,"marketCap":267683442},{"date":"2022-01-14","current":-7.786183,"twenty":-16.554301,"median":-8.158065,"eighty":-0.96443,"marketCap":285846131},{"date":"2022-01-21","current":-6.643582,"twenty":-16.554301,"median":-8.158065,"eighty":-0.990095,"marketCap":243898968},{"date":"2022-01-28","current":-6.737817,"twenty":-16.554301,"median":-8.158065,"eighty":-1.013469,"marketCap":247358528},{"date":"2022-02-04","current":-6.584685,"twenty":-16.554301,"median":-8.158065,"eighty":-1.027849,"marketCap":241736743},{"date":"2022-02-11","current":-6.501997,"twenty":-16.554301,"median":-8.158065,"eighty":-1.040287,"marketCap":243642404},{"date":"2022-02-18","current":-6.132434,"twenty":-16.554301,"median":-8.158065,"eighty":-1.062721,"marketCap":229794168},{"date":"2022-02-25","current":-6.490448,"twenty":-16.554301,"median":-8.158065,"eighty":-1.085691,"marketCap":243209647},{"date":"2022-03-04","current":-5.728225,"twenty":-16.554301,"median":-8.158065,"eighty":-1.106996,"marketCap":214647660},{"date":"2022-03-11","current":-5.312467,"twenty":-16.554301,"median":-8.158065,"eighty":-1.158225,"marketCap":199068394},{"date":"2022-03-18","current":-5.77442,"twenty":-16.554301,"median":-8.158065,"eighty":-1.189564,"marketCap":216378690},{"date":"2022-03-25","current":-4.619536,"twenty":-16.554301,"median":-8.158065,"eighty":-1.226566,"marketCap":173102952},{"date":"2022-04-01","current":-4.515597,"twenty":-16.554301,"median":-8.158065,"eighty":-1.233418,"marketCap":169208135},{"date":"2022-04-08","current":-4.527145,"twenty":-16.554301,"median":-8.158065,"eighty":-1.247123,"marketCap":169640892},{"date":"2022-04-14","current":-3.811117,"twenty":-16.554301,"median":-8.158065,"eighty":-1.26768,"marketCap":142809935},{"date":"2022-04-22","current":-3.314517,"twenty":-16.554301,"median":-8.158065,"eighty":-1.280014,"marketCap":124201368},{"date":"2022-04-29","current":-3.306011,"twenty":-16.554301,"median":-8.158065,"eighty":-1.300358,"marketCap":123882641},{"date":"2022-05-06","current":-3.525642,"twenty":-16.554301,"median":-8.158065,"eighty":-1.396504,"marketCap":132112607},{"date":"2022-05-13","current":-3.408543,"twenty":-16.554301,"median":-8.158065,"eighty":-1.567315,"marketCap":123048702},{"date":"2022-05-20","current":-3.756599,"twenty":-16.554301,"median":-8.158065,"eighty":-1.692999,"marketCap":135613535},{"date":"2022-05-27","current":-4.188668,"twenty":-16.554301,"median":-8.158065,"eighty":-1.773964,"marketCap":151211257},{"date":"2022-06-03","current":-4.464712,"twenty":-16.554301,"median":-8.158065,"eighty":-1.827608,"marketCap":161176469},{"date":"2022-06-10","current":-4.020641,"twenty":-16.554301,"median":-8.158065,"eighty":-1.879456,"marketCap":145145476},{"date":"2022-06-17","current":-4.716752,"twenty":-16.554301,"median":-8.158065,"eighty":-1.922204,"marketCap":170275141},{"date":"2022-06-24","current":-5.388859,"twenty":-16.554579,"median":-8.158065,"eighty":-1.986916,"marketCap":194538265},{"date":"2022-07-01","current":-4.920909,"twenty":-16.554579,"median":-8.158065,"eighty":-2.104754,"marketCap":177645226},{"date":"2022-07-08","current":-5.545024,"twenty":-16.554579,"median":-8.158065,"eighty":-2.147391,"marketCap":200175840},{"date":"2022-07-15","current":-4.608851,"twenty":-16.554579,"median":-8.158065,"eighty":-2.267774,"marketCap":166379919},{"date":"2022-07-22","current":-4.584847,"twenty":-16.554579,"median":-8.158065,"eighty":-2.342744,"marketCap":165513357},{"date":"2022-07-29","current":-4.596849,"twenty":-16.554579,"median":-8.158065,"eighty":-2.385632,"marketCap":165946638},{"date":"2022-08-05","current":-5.052933,"twenty":-16.554579,"median":-8.158065,"eighty":-2.441697,"marketCap":182411317},{"date":"2022-08-12","current":-4.922494,"twenty":-16.554579,"median":-8.158065,"eighty":-2.459289,"marketCap":180842316},{"date":"2022-08-19","current":-5.170389,"twenty":-16.554579,"median":-8.158065,"eighty":-2.496095,"marketCap":189949483},{"date":"2022-08-26","current":-4.62738,"twenty":-16.554579,"median":-8.158065,"eighty":-2.52589,"marketCap":170000451},{"date":"2022-09-02","current":-4.532944,"twenty":-16.554579,"median":-8.158065,"eighty":-2.565239,"marketCap":166531054},{"date":"2022-09-09","current":-4.957907,"twenty":-16.554579,"median":-8.158065,"eighty":-2.577527,"marketCap":182143340},{"date":"2022-09-16","current":-4.875276,"twenty":-16.554579,"median":-8.158065,"eighty":-2.615174,"marketCap":179107618},{"date":"2022-09-23","current":-4.131589,"twenty":-16.554579,"median":-8.158065,"eighty":-2.629256,"marketCap":151786117},{"date":"2022-09-30","current":-3.647603,"twenty":-16.554579,"median":-8.158065,"eighty":-2.650331,"marketCap":134005457},{"date":"2022-10-07","current":-3.989935,"twenty":-16.554579,"median":-8.158065,"eighty":-2.709192,"marketCap":146582021},{"date":"2022-10-14","current":-3.730235,"twenty":-16.554579,"median":-8.158065,"eighty":-2.97036,"marketCap":137041179},{"date":"2022-10-21","current":-3.541362,"twenty":-16.554579,"median":-8.158065,"eighty":-3.086022,"marketCap":130102386},{"date":"2022-10-28","current":-4.10798,"twenty":-16.554579,"median":-8.158065,"eighty":-3.173453,"marketCap":150918767},{"date":"2022-11-04","current":-4.084371,"twenty":-16.554579,"median":-8.158065,"eighty":-3.238566,"marketCap":150051418},{"date":"2022-11-11","current":-3.97813,"twenty":-16.554579,"median":-8.158065,"eighty":-3.306011,"marketCap":146148346},{"date":"2022-11-18","current":-3.505949,"twenty":-16.554579,"median":-8.158065,"eighty":-3.349291,"marketCap":128801362},{"date":"2022-11-25","current":-3.564971,"twenty":-16.554579,"median":-8.158065,"eighty":-3.375176,"marketCap":130969735},{"date":"2022-12-02","current":-3.423317,"twenty":-16.554579,"median":-8.158065,"eighty":-3.422112,"marketCap":125765639},{"date":"2022-12-09","current":-2.821285,"twenty":-16.554579,"median":-8.158065,"eighty":-3.422112,"marketCap":103648234},{"date":"2022-12-16","current":-2.455345,"twenty":-16.554579,"median":-8.158065,"eighty":-3.422112,"marketCap":90204320},{"date":"2022-12-23","current":-2.70324,"twenty":-16.554579,"median":-8.158065,"eighty":-3.422112,"marketCap":99311487},{"date":"2022-12-30","current":-2.727829,"twenty":-16.554579,"median":-8.158065,"eighty":-3.422112,"marketCap":102647678},{"date":"2023-01-06","current":-2.890338,"twenty":-16.554579,"median":-8.158065,"eighty":-3.422112,"marketCap":108762858},{"date":"2023-01-13","current":-3.319826,"twenty":-16.554579,"median":-8.158065,"eighty":-3.422112,"marketCap":124924408},{"date":"2023-01-20","current":-3.296611,"twenty":-16.554579,"median":-8.158065,"eighty":-3.423904,"marketCap":124050810},{"date":"2023-01-27","current":-3.180533,"twenty":-16.554579,"median":-8.158065,"eighty":-3.423904,"marketCap":119682824},{"date":"2023-02-03","current":-3.110886,"twenty":-16.554579,"median":-8.158065,"eighty":-3.423904,"marketCap":117062032},{"date":"2023-02-10","current":-3.238572,"twenty":-16.554579,"median":-8.158065,"eighty":-3.423904,"marketCap":121866817},{"date":"2023-02-17","current":-3.60613,"twenty":-16.554579,"median":-8.158065,"eighty":-3.425791,"marketCap":132966149},{"date":"2023-02-24","current":-3.096052,"twenty":-16.554579,"median":-8.158065,"eighty":-3.427633,"marketCap":114158437},{"date":"2023-03-03","current":-3.511232,"twenty":-16.554579,"median":-8.158065,"eighty":-3.434617,"marketCap":129467040},{"date":"2023-03-10","current":-2.799496,"twenty":-16.554579,"median":-8.158065,"eighty":-3.438897,"marketCap":103223721},{"date":"2023-03-17","current":-2.633424,"twenty":-16.554579,"median":-8.158065,"eighty":-3.438897,"marketCap":97100280},{"date":"2023-03-24","current":-2.680873,"twenty":-16.554579,"median":-8.158065,"eighty":-3.438897,"marketCap":98849834},{"date":"2023-03-31","current":-2.752046,"twenty":-16.554301,"median":-8.158065,"eighty":-3.436757,"marketCap":101474166},{"date":"2023-04-06","current":-2.704597,"twenty":-16.554301,"median":-8.158065,"eighty":-3.436757,"marketCap":99724612},{"date":"2023-04-14","current":-2.884201,"twenty":-16.554579,"median":-8.158065,"eighty":-3.438897,"marketCap":106347001},{"date":"2023-04-21","current":-3.109715,"twenty":-16.554579,"median":-8.158065,"eighty":-3.438897,"marketCap":114662198},{"date":"2023-04-28","current":-2.528127,"twenty":-16.554579,"median":-8.158065,"eighty":-3.438897,"marketCap":93217741},{"date":"2023-05-05","current":-2.885438,"twenty":-16.554579,"median":-8.158065,"eighty":-3.438897,"marketCap":106392623},{"date":"2023-05-12","current":-3.28552,"twenty":-16.554579,"median":-8.158065,"eighty":-3.438897,"marketCap":121144541},{"date":"2023-05-19","current":-3.220882,"twenty":-16.554579,"median":-8.158065,"eighty":-3.438897,"marketCap":113992096},{"date":"2023-05-26","current":-2.969054,"twenty":-16.554579,"median":-8.158065,"eighty":-3.438897,"marketCap":105079495},{"date":"2023-06-02","current":-3.04486,"twenty":-16.554579,"median":-8.158065,"eighty":-3.438897,"marketCap":107762376},{"date":"2023-06-09","current":-3.221739,"twenty":-16.554579,"median":-8.158065,"eighty":-3.438897,"marketCap":114022431},{"date":"2023-06-16","current":-3.04486,"twenty":-16.554579,"median":-8.158065,"eighty":-3.438897,"marketCap":107762376},{"date":"2023-06-23","current":-2.842711,"twenty":-16.554858,"median":-8.158065,"eighty":-3.438897,"marketCap":100608027},{"date":"2023-06-30","current":-3.006957,"twenty":-16.555136,"median":-8.158065,"eighty":-3.445225,"marketCap":106420936},{"date":"2023-07-07","current":-3.095397,"twenty":-16.555136,"median":-8.158065,"eighty":-3.445225,"marketCap":109550963},{"date":"2023-07-14","current":-2.95642,"twenty":-16.555136,"median":-8.158065,"eighty":-3.445225,"marketCap":104632348},{"date":"2023-07-21","current":-2.63008,"twenty":-16.555136,"median":-8.158065,"eighty":-3.470535,"marketCap":93082691},{"date":"2023-07-28","current":-2.282963,"twenty":-16.555136,"median":-8.158065,"eighty":-3.470535,"marketCap":80797665},{"date":"2023-08-04","current":-2.096054,"twenty":-16.555136,"median":-8.158065,"eighty":-3.470535,"marketCap":74182652},{"date":"2023-08-11","current":-1.895794,"twenty":-16.555136,"median":-8.158065,"eighty":-3.470535,"marketCap":67095137},{"date":"2023-08-18","current":-1.746139,"twenty":-16.555136,"median":-8.158065,"eighty":-3.470535,"marketCap":59075121},{"date":"2023-08-25","current":-1.899799,"twenty":-16.555136,"median":-8.158065,"eighty":-3.470535,"marketCap":64273731},{"date":"2023-09-01","current":-1.941706,"twenty":-16.555136,"median":-8.158065,"eighty":-3.470535,"marketCap":65691534},{"date":"2023-09-08","current":-1.788046,"twenty":-16.555136,"median":-8.158065,"eighty":-3.438897,"marketCap":60492924},{"date":"2023-09-15","current":-1.732169,"twenty":-16.555136,"median":-8.158065,"eighty":-3.424794,"marketCap":58602520},{"date":"2023-09-22","current":-1.704231,"twenty":-16.555136,"median":-8.158065,"eighty":-3.408904,"marketCap":57657318},{"date":"2023-09-29","current":-1.690262,"twenty":-16.555136,"median":-8.158065,"eighty":-3.359935,"marketCap":57184717},{"date":"2023-10-06","current":-1.522633,"twenty":-16.555136,"median":-8.158065,"eighty":-3.340953,"marketCap":51513505},{"date":"2023-10-13","current":-1.648355,"twenty":-16.555136,"median":-8.158065,"eighty":-3.323464,"marketCap":55766914},{"date":"2023-10-20","current":-1.578509,"twenty":-16.555136,"median":-8.158065,"eighty":-3.306452,"marketCap":53403909},{"date":"2023-10-27","current":-1.88583,"twenty":-16.555414,"median":-8.188189,"eighty":-3.305529,"marketCap":63801130},{"date":"2023-11-03","current":-2.584285,"twenty":-16.555414,"median":-8.188189,"eighty":-3.27978,"marketCap":87431179},{"date":"2023-11-10","current":-3.338617,"twenty":-16.555414,"median":-8.188189,"eighty":-3.268215,"marketCap":112951631},{"date":"2023-11-17","current":-3.115111,"twenty":-16.555414,"median":-8.188189,"eighty":-3.261184,"marketCap":105390016},{"date":"2023-11-24","current":-3.72287,"twenty":-16.555414,"median":-8.188189,"eighty":-3.259721,"marketCap":125951626},{"date":"2023-12-01","current":-3.323991,"twenty":-16.555414,"median":-8.188189,"eighty":-3.259721,"marketCap":112456809},{"date":"2023-12-08","current":-3.841056,"twenty":-16.555414,"median":-8.181747,"eighty":-3.259642,"marketCap":129950090},{"date":"2023-12-15","current":-4.180842,"twenty":-16.555414,"median":-8.181747,"eighty":-3.259642,"marketCap":141445675},{"date":"2023-12-22","current":-4.123134,"twenty":-16.555414,"median":-8.181747,"eighty":-3.267442,"marketCap":133448746},{"date":"2023-12-29","current":-4.385655,"twenty":-16.555414,"median":-8.188189,"eighty":-3.27978,"marketCap":141945483},{"date":"2024-01-05","current":-3.72163,"twenty":-16.555414,"median":-8.194631,"eighty":-3.300075,"marketCap":120453737},{"date":"2024-01-12","current":-3.798842,"twenty":-16.555414,"median":-8.194631,"eighty":-3.310738,"marketCap":122952777},{"date":"2024-01-19","current":-3.690745,"twenty":-16.555414,"median":-8.203542,"eighty":-3.323991,"marketCap":119454121},{"date":"2024-01-26","current":-4.138576,"twenty":-16.555414,"median":-8.194631,"eighty":-3.334233,"marketCap":133948554},{"date":"2024-02-02","current":-4.231231,"twenty":-16.555414,"median":-8.194631,"eighty":-3.34328,"marketCap":136947402},{"date":"2024-02-09","current":-4.401098,"twenty":-16.555414,"median":-8.194631,"eighty":-3.378353,"marketCap":142445291},{"date":"2024-02-16","current":-4.102727,"twenty":-16.555414,"median":-8.194631,"eighty":-3.410709,"marketCap":127390985},{"date":"2024-02-23","current":-3.755038,"twenty":-16.555414,"median":-8.194631,"eighty":-3.422786,"marketCap":116595138},{"date":"2024-03-01","current":-3.615963,"twenty":-16.555414,"median":-8.188189,"eighty":-3.428196,"marketCap":112276800},{"date":"2024-03-08","current":-3.963652,"twenty":-16.555414,"median":-8.188189,"eighty":-3.470535,"marketCap":123072646},{"date":"2024-03-15","current":-3.668116,"twenty":-16.555414,"median":-8.188189,"eighty":-3.470535,"marketCap":113896177},{"date":"2024-03-22","current":-3.285659,"twenty":-16.555414,"median":-8.188189,"eighty":-3.459169,"marketCap":102020746},{"date":"2024-03-28","current":-3.285659,"twenty":-16.555414,"median":-8.188189,"eighty":-3.423904,"marketCap":102020746},{"date":"2024-04-05","current":-3.024892,"twenty":-16.555414,"median":-8.194631,"eighty":-3.397101,"marketCap":93923861},{"date":"2024-04-12","current":-2.885817,"twenty":-16.555414,"median":-8.194631,"eighty":-3.339444,"marketCap":89605523},{"date":"2024-04-19","current":-2.607666,"twenty":-16.555414,"median":-8.194631,"eighty":-3.324821,"marketCap":80968846},{"date":"2024-04-26","current":-2.520743,"twenty":-16.555414,"median":-8.158065,"eighty":-3.320187,"marketCap":78269884},{"date":"2024-05-03","current":-2.572897,"twenty":-16.555414,"median":-8.063626,"eighty":-3.305715,"marketCap":79889261},{"date":"2024-05-10","current":-2.62505,"twenty":-16.555414,"median":-7.973149,"eighty":-3.284927,"marketCap":81508638},{"date":"2024-05-17","current":-2.523034,"twenty":-16.555414,"median":-7.880326,"eighty":-3.268572,"marketCap":75570923},{"date":"2024-05-24","current":-2.288752,"twenty":-16.555414,"median":-7.880326,"eighty":-3.257706,"marketCap":68553623},{"date":"2024-05-31","current":-2.180622,"twenty":-16.555414,"median":-7.880326,"eighty":-3.236893,"marketCap":65314869},{"date":"2024-06-07","current":-2.314496,"twenty":-16.555414,"median":-7.880326,"eighty":-3.221739,"marketCap":69324719},{"date":"2024-06-14","current":-2.332578,"twenty":-16.555414,"median":-7.8854,"eighty":-3.215662,"marketCap":69866318},{"date":"2024-06-21","current":-2.224086,"twenty":-16.555414,"median":-7.793671,"eighty":-3.181352,"marketCap":66616722},{"date":"2024-06-28","current":-2.133676,"twenty":-16.56918,"median":-7.730784,"eighty":-3.173129,"marketCap":63908725},{"date":"2024-07-05","current":-1.98902,"twenty":-16.56918,"median":-7.646826,"eighty":-3.154082,"marketCap":59575930},{"date":"2024-07-12","current":-2.242168,"twenty":-16.56918,"median":-7.50542,"eighty":-3.134102,"marketCap":67158321},{"date":"2024-07-15","current":-2.314496,"twenty":-16.56918,"median":-7.491698,"eighty":-3.128727,"marketCap":69324719},{"date":"2024-08-02","current":-2.688567,"twenty":-16.607352,"median":-7.295099,"eighty":-3.110886,"marketCap":80529027},{"date":"2024-08-09","current":-2.323015,"twenty":-16.607352,"median":-7.150096,"eighty":-3.099278,"marketCap":69579874},{"date":"2024-08-16","current":-2.27142,"twenty":-16.607352,"median":-6.843832,"eighty":-3.09443,"marketCap":66100881},{"date":"2024-08-23","current":-2.345527,"twenty":-16.607352,"median":-6.688854,"eighty":-3.070128,"marketCap":68257484},{"date":"2024-08-30","current":-2.292699,"twenty":-16.607352,"median":-6.596464,"eighty":-3.04486,"marketCap":66720153},{"date":"2024-09-06","current":-2.303265,"twenty":-16.607352,"median":-6.46689,"eighty":-3.041239,"marketCap":67027619},{"date":"2024-09-13","current":-2.535705,"twenty":-16.607352,"median":-6.274951,"eighty":-3.024892,"marketCap":73791874},{"date":"2024-09-20","current":-2.324396,"twenty":-16.607352,"median":-6.057367,"eighty":-2.994322,"marketCap":67642551},{"date":"2024-09-27","current":-2.218741,"twenty":-16.607352,"median":-5.699353,"eighty":-2.972739,"marketCap":64567890},{"date":"2024-10-04","current":-2.303265,"twenty":-16.607352,"median":-5.568012,"eighty":-2.95642,"marketCap":67027619},{"date":"2024-10-11","current":-2.134218,"twenty":-16.607352,"median":-5.39486,"eighty":-2.919808,"marketCap":62108161},{"date":"2024-10-18","current":-2.007433,"twenty":-16.607352,"median":-5.332349,"eighty":-2.918118,"marketCap":58418567},{"date":"2024-10-25","current":-1.91171,"twenty":-16.607352,"median":-5.243092,"eighty":-2.890338,"marketCap":55632924},{"date":"2024-10-31","current":-1.897341,"twenty":-16.607352,"median":-5.044113,"eighty":-2.883743,"marketCap":55214770},{"date":"2024-11-08","current":-1.478527,"twenty":-16.609949,"median":-4.981516,"eighty":-2.848594,"marketCap":43026812},{"date":"2024-11-15","current":-1.18354,"twenty":-16.609949,"median":-4.934298,"eighty":-2.836112,"marketCap":34442357},{"date":"2024-11-22","current":-1.277361,"twenty":-16.609949,"median":-4.898885,"eighty":-2.816927,"marketCap":37172656},{"date":"2024-11-29","current":-1.391679,"twenty":-16.609949,"median":-4.828057,"eighty":-2.773442,"marketCap":40499440},{"date":"2024-12-06","current":-1.228732,"twenty":-16.609949,"median":-4.756274,"eighty":-2.752046,"marketCap":35757501},{"date":"2024-12-13","current":-1.616384,"twenty":-16.609949,"median":-4.688829,"eighty":-2.728223,"marketCap":47038597},{"date":"2024-12-20","current":-1.677557,"twenty":-16.609949,"median":-4.668862,"eighty":-2.705881,"marketCap":48818815},{"date":"2024-12-27","current":-1.545563,"twenty":-16.609949,"median":-4.632739,"eighty":-2.704326,"marketCap":44977627},{"date":"2025-01-03","current":-0.909709,"twenty":-16.609949,"median":-4.608851,"eighty":-2.687028,"marketCap":26473567},{"date":"2025-01-10","current":-0.803368,"twenty":-16.612546,"median":-4.588407,"eighty":-2.645781,"marketCap":23378922},{"date":"2025-01-17","current":-1.07211,"twenty":-16.612546,"median":-4.535819,"eighty":-2.62505,"marketCap":29568709},{"date":"2025-01-24","current":-1.05142,"twenty":-16.56918,"median":-4.511084,"eighty":-2.607666,"marketCap":28998085},{"date":"2025-01-31","current":-1.073453,"twenty":-16.521638,"median":-4.464712,"eighty":-2.573626,"marketCap":29605762},{"date":"2025-02-07","current":-1.056257,"twenty":-16.393722,"median":-4.436345,"eighty":-2.54602,"marketCap":29131477},{"date":"2025-02-14","current":-1.088501,"twenty":-16.278983,"median":-4.396899,"eighty":-2.522118,"marketCap":30020762},{"date":"2025-02-21","current":-1.168806,"twenty":-16.266724,"median":-4.365891,"eighty":-2.492369,"marketCap":32660481},{"date":"2025-02-28","current":-0.910729,"twenty":-16.242394,"median":-4.296201,"eighty":-2.463292,"marketCap":25448923},{"date":"2025-03-07","current":-0.94361,"twenty":-16.23404,"median":-4.238424,"eighty":-2.421882,"marketCap":26367741},{"date":"2025-03-14","current":-0.834467,"twenty":-16.223526,"median":-4.180842,"eighty":-2.404906,"marketCap":23317885},{"date":"2025-03-21","current":-0.750191,"twenty":-16.223526,"median":-4.154019,"eighty":-2.366658,"marketCap":20962933},{"date":"2025-03-28","current":-0.660113,"twenty":-16.210733,"median":-4.131589,"eighty":-2.354732,"marketCap":18445837},{"date":"2025-04-04","current":-0.549587,"twenty":-16.210733,"median":-4.10798,"eighty":-2.345527,"marketCap":15357375},{"date":"2025-04-11","current":-0.582745,"twenty":-16.20979,"median":-4.099451,"eighty":-2.323015,"marketCap":16283913},{"date":"2025-04-17","current":-0.711507,"twenty":-16.20979,"median":-4.08831,"eighty":-2.314496,"marketCap":19881971},{"date":"2025-04-24","current":-0.864618,"twenty":-16.210733,"median":-4.067958,"eighty":-2.303265,"marketCap":24160424}],"updateTime":1745608710174}}}